210 related articles for article (PubMed ID: 35628578)
1. Association of DNA Methylation of the
Han KM; Choi KW; Kim A; Kang W; Kang Y; Tae WS; Han MR; Ham BJ
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628578
[TBL] [Abstract][Full Text] [Related]
2. Neuroimaging and epigenetic analysis reveal novel epigenetic loci in major depressive disorder.
Yang HH; Han KM; Kim A; Kang Y; Tae WS; Han MR; Ham BJ
Psychol Med; 2024 May; ():1-14. PubMed ID: 38721773
[TBL] [Abstract][Full Text] [Related]
3. Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder.
Han KM; Won E; Sim Y; Kang J; Han C; Kim YK; Kim SH; Joe SH; Lee MS; Tae WS; Ham BJ
Sci Rep; 2017 Feb; 7():42621. PubMed ID: 28198448
[TBL] [Abstract][Full Text] [Related]
4. Altered patterns of association between cortical thickness and subcortical volume in patients with first episode major depressive disorder: A structural MRI study.
Zhao K; Liu H; Yan R; Hua L; Chen Y; Shi J; Yao Z; Lu Q
Psychiatry Res Neuroimaging; 2017 Feb; 260():16-22. PubMed ID: 28012422
[TBL] [Abstract][Full Text] [Related]
5. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder.
Na KS; Won E; Kang J; Chang HS; Yoon HK; Tae WS; Kim YK; Lee MS; Joe SH; Kim H; Ham BJ
Sci Rep; 2016 Feb; 6():21089. PubMed ID: 26876488
[TBL] [Abstract][Full Text] [Related]
7. Integrative omics analysis reveals epigenomic and transcriptomic signatures underlying brain structural deficits in major depressive disorder.
Zheng J; Womer FY; Tang L; Guo H; Zhang X; Tang Y; Wang F
Transl Psychiatry; 2024 Jan; 14(1):17. PubMed ID: 38195555
[TBL] [Abstract][Full Text] [Related]
8. An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report.
Suh JS; Minuzzi L; Raamana PR; Davis A; Hall GB; Harris J; Hassel S; Zamyadi M; Arnott SR; Alders GL; Sassi RB; Milev R; Lam RW; MacQueen GM; Strother SC; Kennedy SH; Frey BN
Neuroimage Clin; 2020; 25():102178. PubMed ID: 32036277
[TBL] [Abstract][Full Text] [Related]
9. Aberrant cortical neurodevelopment in major depressive disorder.
Schmitgen MM; Depping MS; Bach C; Wolf ND; Kubera KM; Vasic N; Hirjak D; Sambataro F; Wolf RC
J Affect Disord; 2019 Jan; 243():340-347. PubMed ID: 30261449
[TBL] [Abstract][Full Text] [Related]
10. Serum FAM19A5 levels: A novel biomarker for neuroinflammation and neurodegeneration in major depressive disorder.
Han KM; Tae WS; Kim A; Kang Y; Kang W; Kang J; Kim YK; Kim B; Seong JY; Ham BJ
Brain Behav Immun; 2020 Jul; 87():852-859. PubMed ID: 32217080
[TBL] [Abstract][Full Text] [Related]
11. Decreased cortical thickness of left premotor cortex as a treatment predictor in major depressive disorder.
Liu X; Hou Z; Yin Y; Xie C; Zhang H; Zhang H; Zhang Z; Yuan Y
Brain Imaging Behav; 2021 Jun; 15(3):1420-1426. PubMed ID: 32710337
[TBL] [Abstract][Full Text] [Related]
12. The interaction between autophagy and neuroinflammation in major depressive disorder: From pathophysiology to therapeutic implications.
Tang M; Liu T; Jiang P; Dang R
Pharmacol Res; 2021 Jun; 168():105586. PubMed ID: 33812005
[TBL] [Abstract][Full Text] [Related]
13. Decreased cortical gyrification in major depressive disorder.
Kang Y; Kang W; Kim A; Tae WS; Ham BJ; Han KM
Psychol Med; 2023 Dec; 53(16):7512-7524. PubMed ID: 37154200
[TBL] [Abstract][Full Text] [Related]
14. The Association of Major Depressive Disorder with Activation of NLRP3 Inflammasome, Lipid Peroxidation, and Total Antioxidant Capacity.
Taene A; Khalili-Tanha G; Esmaeili A; Mobasheri L; Kooshkaki O; Jafari S; Shokouhifar A; Sarab GA
J Mol Neurosci; 2020 Jan; 70(1):65-70. PubMed ID: 31515707
[TBL] [Abstract][Full Text] [Related]
15. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing between major depressive disorder and obsessive-compulsive disorder in children by measuring regional cortical thickness.
Fallucca E; MacMaster FP; Haddad J; Easter P; Dick R; May G; Stanley JA; Rix C; Rosenberg DR
Arch Gen Psychiatry; 2011 May; 68(5):527-33. PubMed ID: 21536980
[TBL] [Abstract][Full Text] [Related]
17. The relationship of impulsivity and cortical thickness in depressed and non-depressed adolescents.
Fradkin Y; Khadka S; Bessette KL; Stevens MC
Brain Imaging Behav; 2017 Oct; 11(5):1515-1525. PubMed ID: 27738995
[TBL] [Abstract][Full Text] [Related]
18. Cortical thickness differences between bipolar depression and major depressive disorder.
Lan MJ; Chhetry BT; Oquendo MA; Sublette ME; Sullivan G; Mann JJ; Parsey RV
Bipolar Disord; 2014 Jun; 16(4):378-88. PubMed ID: 24428430
[TBL] [Abstract][Full Text] [Related]
19. Cortical thickening in remitters compared to non-remitters with major depressive disorder following 8-week antidepressant treatment.
Saricicek Aydogan A; Oztekin E; Esen ME; Dusmez S; Gelal F; Besiroğlu L; Zorlu N
Acta Psychiatr Scand; 2019 Sep; 140(3):217-226. PubMed ID: 31250445
[TBL] [Abstract][Full Text] [Related]
20. Common and Specific Abnormalities in Cortical Thickness in Patients with Major Depressive and Bipolar Disorders.
Niu M; Wang Y; Jia Y; Wang J; Zhong S; Lin J; Sun Y; Zhao L; Liu X; Huang L; Huang R
EBioMedicine; 2017 Feb; 16():162-171. PubMed ID: 28109831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
